US NCPA calls for more competition in health insurance

27 August 2006

The USA-based think-tank the National Center for Policy Analysis has called for the "overlooked" option of creating a competitive insurance market as a solution to the rising costs in US health care, as an alternative to creeping price controls. Devon Herrick, a senior fellow at the NCPA, writing in the Baltimore Sun newspaper, said: "also missing from the debate is why 45 million Americans are uninsured."

Mr Herrick claims that evidence shows that many uninsured people can afford the costs but consider that health care is not good value for money. He also told the Baltimore Sun that he supports the legislative proposal by Republicans US Senator Jim DeMint (South Carolina) and Representative John Shadegg (Arizona) that would permit insurers to sell policies across state lines, arguing that the barriers raise costs and reduce competition.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight